ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: Bayside Health
University of Melbourne
Information provided by: Bayside Health
ClinicalTrials.gov Identifier: NCT00164138
  Purpose

Women with chronic lung disease characterised by chronic cough report urinary incontinence. Recently there have been reports of increased urinary incontinence in girls and women with cystic fibrosis. While coughing is a known risk factor for stress incontinence, other risk factors and causes are poorly understood in this population. Treatment of incontinence for patients with chronic lung disease is also poorly addressed, adding to the burden of disease for women with chronic lung disease, carers and the health system. This project will estimate the prevalence of women with CF and COPD compared to healthy age matched controls and will evaluate the effect of a specific treatment and management program for these patients. The results will be disseminated to respiratory health professionals. We hypothesise that women with chronic cough will have a higher incidence of urinary incontinence than healthy controls and that a specific treatment program will result in alleviation of the problems and improved quality of life.


Condition Intervention
Cystic Fibrosis
Chronic Obstructive Pulmonary Disease (COPD)
Procedure: Pelvic floor muscle training, biofeedback, electrotherapy, bladder training

Genetics Home Reference related topics:   cystic fibrosis   

MedlinePlus related topics:   COPD (Chronic Obstructive Pulmonary Disease)    Cough    Cystic Fibrosis    Pelvic Support Problems    Urinary Incontinence   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Non-Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Official Title:   Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • Symptom measures:
  • 3-day frequency volume chart,
  • 24 hour pad weigh test,
  • accident diary,
  • quality of life using King's Health Questionnaire.
  • pelvic floor muscle function:
  • Trans-abdominal diagnostic ultra-sound
  • EMG study of the pelvic floor muscles

Estimated Enrollment:   180
Study Start Date:   December 2001
Estimated Study Completion Date:   December 2006

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Women with CF and COPD

Exclusion Criteria:

-

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00164138

Locations
Australia, Victoria
The Alfred Hospital    
      Melbourne, Victoria, Australia, 3004
School of Physiotherapy, The University of Melbourne    
      Melbourne, Victoria, Australia, 3052

Sponsors and Collaborators
Bayside Health
University of Melbourne

Investigators
Principal Investigator:     Brenda M Button, DPhty, PhD     The Alfred Hospital, Melbourne    
Study Director:     John W Wilson, MBBS, PhD     The Alfred Hospital, Melbourne    
  More Information


Study ID Numbers:   108/01, Dept. of Health and Aged Care
First Received:   September 13, 2005
Last Updated:   October 17, 2006
ClinicalTrials.gov Identifier:   NCT00164138
Health Authority:   Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
Incontinence, physiotherapy, treatment, pelvic floor muscle function, coughing, forced expirations, lung disease  

Study placed in the following topic categories:
Fibrosis
Urination Disorders
Cough
Signs and Symptoms
Lung Diseases, Obstructive
Digestive System Diseases
Cystic Fibrosis
Respiratory Tract Diseases
Genetic Diseases, Inborn
Urologic Diseases
Lung Diseases
Pancreatic Diseases
Infant, Newborn, Diseases
Urinary Incontinence
Cystic fibrosis
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:
Urological Manifestations
Pathologic Processes

ClinicalTrials.gov processed this record on October 23, 2008




Links to all studies - primarily for crawlers